Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2025/636 of 25 March 2025 amending Annexes III and V to Implementing Regulation (EU) 2020/2235 as regards model animal health certificates, model official certificates, model animal health/official certificates and private attestation, for the entry into the Union or transit through the Union to a third country of consignments of certain categories of animals and goods intended for human consumption

Type Implementing Regulation

Publication 2025-04-30

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 3

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


I, the undersigned, hereby certify that: II.1. I am aware of the relevant requirements of Regulation (EC) No 178/2002 of the European Parliament and of the Council, Regulation (EC) No 852/2004 of the European Parliament and of the Council, Regulation (EC) No 853/2004 of the European Parliament and of the Council, Regulation (EU) 2017/625 of the European Parliament and of the Council, Commission Delegated Regulations (EU) 2019/624 and (EU) 2022/2292, Commission Implementing Regulations (EU) 2019/627 and (EU) 2021/405. II.2. The composite products ⁽²⁾ described in Part I: (a) comply with Article 5 of Regulation (EC) No 852/2004, in particular they come from establishments implementing a programme based on the hazard analysis and critical control points (HACCP) principles, and regularly audited by the competent authorities; (b) comply with Article 6(1), point (b), of Regulation (EC) No 853/2004 on the origin of the products of animal origin used in their production; (c) were produced in accordance with the requirements referred to under point II.1; (d) contain processed products of animal origin that were produced in the establishments located in the Member States or in the third countries authorised for the entry into the Union of those processed products of animal origin; ^{(1) (17)} [(e) fulfil the guarantees covering the concerned animals and products thereof, provided by the control plan submitted in accordance with Article 6(2) of Delegated Regulation (EU) 2022/2292, and the third country(ies) or region(s) thereof of the concerned animals’ and products’ origin is/are listed in Annex -I to Implementing Regulation (EU) 2021/405 for the concerned category(ies) of animals and products.] II.3. The composite products ⁽²⁾ described in Part I contain: ⁽¹⁾ either [II.3.A. Meat products ⁽³⁾ in any quantity except gelatine derived from ruminant bones, collagen derived from ruminant bones and highly refined products referred to in Section XVI of Annex III to Regulation (EC) No 853/2004, which: II.3.A.1. meet the animal health requirements laid down in Commission Delegated Regulation (EU) 2020/692 and contain the following meat constituents which are eligible for the entry into the Union as such and meet the following criteria: Species ⁽⁴⁾ Treatment ⁽⁵⁾ Origin ⁽⁶⁾ Approved establishment(s) ⁽⁷⁾ … … … … ; ⁽¹⁾ [II.3.A.2. originate from: ⁽¹⁾ either [the same country as the country of origin in box I.7;] ⁽¹⁾ and/or [Member States;] ^{(8) (1)} and/or [the zone(s) with code(s) … authorised for the entry into the Union of meat products not required to undergo a specific risk-mitigating treatment as set out in Annex XV to Commission Implementing Regulation (EU) 2021/404 with assigned treatment A, and the zone where the composite products were produced is also authorised for the entry into the Union of meat products with assigned treatment A;]] ⁽¹⁾ [II.3.A.3. contain material from bovine, ovine or caprine animals, and with regard to bovine spongiform encephalopathy (BSE), and: ⁽¹⁾ either [the country or region of their origin is classified in accordance with Commission Decision 2007/453/EC as a country or region posing a negligible BSE risk, and: ⁽¹⁾ either [the animals from which the meat products are derived were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;]]] ⁽¹⁾ and/or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals;]]] ⁽¹⁾ and/or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the meat products do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001 of the European Parliament and of the Council; (b) the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity;]]] ⁽¹⁾ and/or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (a) the meat products do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (b) the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (d) the animals from which the meat products are derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (e) the meat products were produced and handled in a manner which ensures that they do not contain and were not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ and/or [the country or region of their origin is classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; ⁽¹⁾ either [(b) the meat products do not contain and are not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals;] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and: ⁽¹⁾ either [(i) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants has been enforced;]] ⁽¹⁾ and/or [(ii) the treated intestines of bovine, ovine and caprine animal origin do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001;]] ⁽¹⁾ either [(c) the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible or a controlled BSE risk;]]] ⁽¹⁾ and/or [(c) the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (i) the animals from which the meat products are derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (ii) the meat products were produced and handled in a manner which ensures that they do not contain and were not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ and/or [the country or region of their origin is classified in accordance with Decision 2007/453/EC as a country or region with an undetermined BSE risk, and: (a) the animals from which the meat products are derived have not been: (i) slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (ii) fed meat-and-bone meal or greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; ⁽¹⁾ either [(b) the meat products do not contain and are not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;]]] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and: ⁽¹⁾ either [(i) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants has been enforced;]]]] ⁽¹⁾ and/or [(ii) the treated intestines of bovine, ovine and caprine animal origin do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001.]]]] ⁽¹⁾ and/or [II.3.B. Dairy products or colostrum-based products ⁽⁹⁾ in any quantity that meet the animal health requirements laid down in Delegated Regulation (EU) 2020/692 and therefore are eligible for the entry into the Union as such, and: (a) have been produced in: ^{(1) (10)} either [the zone(s) with code(s) … as listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 which has/have been free from foot and mouth disease and infection with rinderpest virus for the period of at least the last 12 months prior to the date of milking and, during that period, no vaccination against those diseases has been carried out;] ⁽¹⁾ and/or [the zone(s) with code(s) … as listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404 and the treatment applied complies with the minimum treatment provided for in Article 157 of and Annex XXVII to Delegated Regulation (EU) 2020/692;] ^{(1) (10)} and/or [Member States;] and the establishment(s) … (approval number(s) of the establishment(s) of origin of the dairy products or the colostrum-based products contained in the composite products authorised at the date of production for entry into the Union of dairy products or colostrum-based products); (b) originate in: ⁽¹⁾ either [the same country as the country referred to in box I.7;] ^{(1) (10)} and/or [Member States;] ^{(1) (10)} and/or [the zone(s) with code(s) … authorised for the entry into the Union of milk, colostrum, dairy products and colostrum-based products in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404, and the zone where the composite products were produced is also authorised, under the same conditions, for the entry into the Union of milk, colostrum, dairy products and colostrum-based products and listed in Part 1 of that Annex;]] ⁽¹⁾ [(c) are dairy products produced from raw milk and/or dairy products therefrom, and were made from raw milk obtained from ⁽¹⁾ either [[Bos taurus] ⁽¹⁾, [Ovis aries] ⁽¹⁾, [Capra hircus] ⁽¹⁾, [Bubalus bubalis] ⁽¹⁾, [Camelus dromedarius] ⁽¹⁾ and prior to dispatch to the Union have undergone or been produced from raw milk and/or dairy products therefrom, which has/have undergone ^{(1) (10)} either [at least a pasteurisation treatment involving a single heat treatment with a heating effect at least equivalent to that achieved by a pasteurisation process of at least 72°C for 15 seconds and where applicable, sufficient to ensure a negative reaction to an alkaline phosphatase test applied immediately after the heat treatment;]]]] ^{(1) (11)} or [⁽¹⁾ either [a sterilisation process, to achieve an F0 value equal to or greater than 3;]]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time;]]]]] ⁽¹⁾ or [a high temperature short time (HTST) pasteurisation treatment at 72°C for 15 seconds applied twice to milk with a pH equal to or greater than 7,0 achieving, where applicable, a negative reaction to an alkaline phosphatase test, applied immediately after the heat treatment;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment of milk with a pH below 7,0;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment combined with another physical treatment by ⁽¹⁾ either [lowering the pH below 6 for 1 hour;]]]]]] ⁽¹⁾ or [additional heating equal to or greater than 72°C, combined with desiccation;]]]]]] ⁽¹⁾ or [animals other than Bos taurus, Ovis aries, Capra hircus, Bubalus bubalis and Camelus dromedarius, and prior to dispatch to the Union the dairy products have undergone or been produced from raw milk and/or dairy products therefrom which has/have undergone ⁽¹⁾ either [a sterilisation process, to achieve an F0 value equal to or greater than 3;]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time;]]]]] ⁽¹⁾ [(d) are colostrum-based products and come from a zone listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 for entry into the Union of milk, colostrum and colostrum-based products.]] ⁽¹⁾ and/or [II.3.C. Fishery products that originate from approved establishment(s) No(s) … … ⁽¹²⁾ situated in the country(ies) … … ⁽¹³⁾.] ⁽¹⁾ and/or [II.3.D. Egg products that: II.3.D.1. originate from approved establishment(s) No(s) … ⁽¹²⁾ situated in: ⁽¹⁾ either [the zone(s) with code(s) … ⁽¹⁴⁾ which at the date of issue of this animal health/official certificate is/are listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404 for entry into the Union of egg products and applies a disease surveillance programme for highly pathogenic avian influenza that complies with the requirements referred to in Article 160 of Delegated Regulation (EU) 2020/692;] ⁽¹⁾ and/or [Member States;] II.3.D.2. were produced from eggs coming from establishments which satisfy the requirements of Section X of Annex III to Regulation (EC) No 853/2004 in which, during the period of at least the last 30 days prior to the date of collection of the eggs, no outbreak of highly pathogenic avian influenza and infection with Newcastle disease virus has occurred, and: ⁽¹⁾ either [(a) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza during the period of at least the last 30 days prior to the date of collection of the eggs;] ⁽¹⁾ or [(a) the egg products are ⁽¹⁾ either [liquid egg white which was treated ⁽¹⁾ either [with 55,6°C for 870 seconds;]]] ⁽¹⁾ or [with 56,7°C for 232 seconds;]]] ⁽¹⁾ or [10 % salted yolk which was treated with 62,2°C for 138 seconds;]] ⁽¹⁾ or [dried egg white which was treated ⁽¹⁾ either [with 67°C for 20 hours;]]] ⁽¹⁾ or [with 54,4°C for 50,4 hours;]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ or [whole egg blends which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [treated with 61,1°C for 94 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ either [(b) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of infection with Newcastle disease virus during the period of at least the last 30 days prior to the date of collection of the eggs.]] ⁽¹⁾ or [(b) the egg products are ⁽¹⁾ either [liquid egg white which was treated ⁽¹⁾ either [with 55^oC for 2 278 seconds.]]]] ⁽¹⁾ or [with 57^oC for 986 seconds.]]]] ⁽¹⁾ or [with 59^oC for 301 seconds.]]]] ⁽¹⁾ or [10 % salted yolk which was treated with 55^oC for 176 seconds.]]] ⁽¹⁾ or [dried egg white which was treated with 57^oC for 50,4 hours.]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 55^oC for 2 521 seconds.]]]] ⁽¹⁾ or [treated with 57^oC for 1 596 seconds.]]]] ⁽¹⁾ or [treated with 59^oC for 674 seconds.]]]] ⁽¹⁾ or [completely cooked.]]]] ⁽¹⁾ and/or [II.3.E. Gelatine or collagen derived from ruminant bones: II.3.E.1. which originates from approved establishment(s) No(s) … … ⁽¹²⁾ situated in the country(ies) … … ⁽¹⁵⁾; II.3.E.2. for which, with regard to bovine spongiform encephalopathy (BSE), ⁽¹⁾ either [the country or region of its origin is classified in accordance with Decision 2007/453/EC as a country or region posing a negligible bovine spongiform encephalopathy (BSE) risk, and: ⁽¹⁾ either [the animals from which the gelatine or collagen is derived, were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;]]] ⁽¹⁾ and/or [the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and the gelatine or collagen does not contain and is not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals;]]] ⁽¹⁾ and/or [the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the gelatine or collagen does not contain and is not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001 of the European Parliament and of the Council; (b) the gelatine or collagen does not contain and is not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the gelatine or collagen is derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity;]]] ⁽¹⁾ and/or [the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (a) the gelatine or collagen does not contain and is not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (b) the gelatine or collagen does not contain and is not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the gelatine or collagen is derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (d) the animals from which the gelatine or collagen is derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (e) the gelatine or collagen was produced and handled in a manner which ensures that it does not contain and was not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ or [the country or region of its origin is classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the animals from which the gelatine or collagen is derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (b) the gelatine or collagen does not contain and is not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; ⁽¹⁾ either [(c) the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible or a controlled BSE risk;]]] ⁽¹⁾ and/or [(c) the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (i) the animals from which the gelatine or collagen is derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (ii) the gelatine or collagen was produced and handled in a manner which ensures that it does not contain and was not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ or [the country or region of its origin is classified in accordance with Decision 2007/453/EC as a country or region with an undetermined BSE risk, and: (a) the animals from which the gelatine or collagen is derived have not been: (i) slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (ii) fed meat-and-bone meal or greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (b) the gelatine or collagen does not contain and is not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) nervous and lymphatic tissues exposed during the deboning process;]] ⁽¹⁾ and/or [II.3.F. Processed honey and other processed apiculture products intended for human consumption that originate from listed/registered establishment(s) No(s). … … ⁽¹²⁾ situated in the country(ies) … … ⁽¹⁶⁾.] Notes In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health/official certificate include the United Kingdom in respect of Northern Ireland. This animal health/official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.7 : Insert the ISO code of the country of origin of the composite products containing meat products as listed in Annex XV to Implementing Regulation (EU) 2021/404 or in Annex VII to Implementing Regulation (EU) 2021/405, or colostrum-based products as listed in Annex XVII to Implementing Regulation (EU) 2021/404, or dairy products as listed in Annex XVII or XVIII to Implementing Regulation (EU) 2021/404 or in Annex X to Implementing Regulation (EU) 2021/405, or fishery products as listed in Annex IX to Implementing Regulation (EU) 2021/405, or egg products as listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404, or gelatine and collagen derived from bovine, ovine and caprine animals and intended for human consumption as listed in Annex XII to Implementing Regulation (EU) 2021/405, or honey and apiculture products as listed in Annex -I to Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “honey”. Box reference I.11 : Name, address and registration/approval number (if available) of the establishment(s) of shipping of the composite products. Name of the country of dispatch shall be the same as the country of origin in box I.7. Box reference I.15 : Registration number (railway wagons or container and road vehicles), flight number (aircraft) or name (vessel) shall be provided. In the case of transport in containers, their registration number and, where there is a serial number of the seal, it shall be indicated in box I.19. In the case of unloading and reloading, the consignor shall inform the border control post of entry into the Union. Box reference I.19 : For containers or boxes, the container number and the seal number (if applicable) shall be included. Box reference I.27 : “CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 1517 , 1518 , 1601 00 , 1602 , 1603 00 , 1604 , 1605 , 1702 , 1704 , 1806 , 1901 , 1902 , 1904 , 1905 , 2001 , 2004 , 2005 , 2008 , 2101 , 2103 , 2104 , 2105 00 , 2106 , 2202 or 2208 . “Manufacturing plant”: Insert the name and approval number(s) (if available) of the establishment(s) of production of the composite products. “Nature of commodity”: In the case of composite products containing meat products indicate “meat products”. In the case of composite products containing dairy products indicate “dairy products”. In the case of composite products containing colostrum-based products indicate “colostrum-based products”. In the case of composite products containing fishery products specify whether aquaculture or wild origin. In the case of composite products containing egg products indicate “egg products”. In the case of composite products containing gelatine or collagen derived from ruminant bones indicate “gelatine” or “collagen”, or both. In the case of composite products containing processed honey or other apiculture products indicate “processed honey” or “other processed apiculture products”. Part II: ⁽¹⁾ Keep if appropriate. ⁽²⁾ Composite products shall only be permitted to enter into the Union if the products of animal origin contained therein were obtained after the date of authorisation of the third country or territory, or zone thereof, where the products of animal origin were produced, for the entry into the Union of the specific species and category of products of animal origin, or during a period where animal health restriction measures taken by the Union were not in place against the entry into the Union of those products from that third country or territory, or zone thereof, or during a period where the authorisation of that third country or territory, or zone thereof for the entry into the Union of those products was not suspended. ⁽³⁾ “Meat products” as defined in point 7.1 of Annex I to Regulation (EC) No 853/2004. ⁽⁴⁾ Insert the code for the relevant species of the meat products, where BOV = domestic bovine animals (Bos taurus, Bison bison, Bubalus bubalis and their cross-breeds), OVI = domestic sheep (Ovis aries) and goats (Capra hircus), EQU = domestic solipeds (Equus caballus, Equus asinus and their cross-breeds), POR = domestic porcine animals (Sus scrofa), RM = farmed rabbits, POU = domestic poultry, RAT = ratites, RUF = animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), camelid animals and cervid animals kept as farmed game, RUW = wild animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), wild camelid animals and wild cervid animals, SUF = animals kept as farmed game of wild breeds of porcine animals and animals of the family Tayassuidae, SUW = wild animals of wild breeds of porcine animals and animals of the family Tayassuidae, EQW = wild game solipeds, WL = wild leporidae, WM = wild land mammals other than ungulates and leporidae, GBM = game birds. ⁽⁵⁾ Insert A, B, C, D, E or F for the required treatment as specified and defined in Annex XV to Implementing Regulation (EU) 2021/404. ⁽⁶⁾ Insert the code of the zone of origin of the meat products, as listed in Annex XV to Implementing Regulation (EU) 2021/404 or “EU” for the meat products originating from the Member States. ⁽⁷⁾ Insert the EU approval number of the establishments of origin of the meat products contained in the composite products. ⁽⁸⁾ Delete if the meat products are obtained from EQU, EQW, WL, RM or WM as defined in note (4). ⁽⁹⁾ “Dairy products” mean dairy products for human consumption as defined in point 7.2 of Annex I to Regulation (EC) No 853/2004. “Colostrum-based products” mean colostrum-based products for human consumption as defined in Section IX, point 2, of Annex III to Regulation (EC) No 853/2004. ⁽¹⁰⁾ This certification alternative is only allowed for dairy products originating and produced in the zone(s) listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 or in the Member States, or both and which are contained in the composite products dispatched to the Union from the zone(s) referred to in box I.7 and listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404. ⁽¹¹⁾ This certification alternative is only allowed for dairy products produced in the zone(s) listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404, which are contained in the composite products dispatched to the Union from the zone(s) referred to in box I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. Selected heat treatment shall previously have been applied in the zone referred to in box I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. ⁽¹²⁾ Approval numbers (or registration numbers, in the case of processed honey and other processed apiculture products) of respectively the fishery product establishments, the egg product establishments, the gelatine/collagen establishments, or honey or apiculture products establishments listed in accordance with Article 127(3), point (e), of Regulation (EU) 2017/625 or, if the fishery products, egg products gelatine/collagen, or processed honey and other processed apiculture products originate from the Member States, the approval numbers of the fishery product establishments, the egg product establishments, or the gelatine/collagen establishments approved in accordance with Article 4(2) of Regulation (EC) No 853/2004, or the registration numbers of the honey or apiculture products establishments registered in accordance with Article 6 of Regulation (EC) No 852/2004. ⁽¹³⁾ Country of origin authorised for the entry into the Union of certain fishery products as listed in Annex IX to Implementing Regulation (EU) 2021/405. In the case of fishery products derived from bivalve molluscs, the country of origin shall be authorised for the entry into the Union of live, chilled, frozen or processed bivalve molluscs, echinoderms, tunicates and marine gastropods as listed in Annex VIII to Implementing Regulation (EU) 2021/405. If the fishery products originate from the Member States, the Member State of origin shall be indicated. ⁽¹⁴⁾ Code of the zone as listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404. ⁽¹⁵⁾ Country of origin authorised for the entry into the Union of gelatine and collagen, derived from bovine, ovine and caprine animals, and intended for human consumption as listed in Annex XII to Implementing Regulation (EU) 2021/405. If the gelatine or collagen derived from ruminant bones originates from the Member States, the Member State of origin shall be indicated. ⁽¹⁶⁾ Country of origin authorised for the entry into the Union of honey and apiculture products as listed in Annex -I to Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “honey”. ⁽¹⁷⁾ Not required for gelatine, collagen and fishery products from wild catch. ⁽¹⁸⁾ To be signed by: (a) an official veterinarian, (b) a certifying officer or an official veterinarian for composite products containing only egg products or fishery products.

I, the undersigned, hereby certify that: II.1. I am aware of the relevant requirements of Regulation (EC) No 178/2002 of the European Parliament and of the Council, Regulation (EC) No 852/2004 of the European Parliament and of the Council, Regulation (EC) No 853/2004 of the European Parliament and of the Council, Regulation (EU) 2017/625 of the European Parliament and of the Council, Commission Delegated Regulations (EU) 2019/624 and (EU) 2022/2292, Commission Implementing Regulations (EU) 2019/627 and (EU) 2021/405. II.2. The composite products ⁽²⁾ described in Part I: (a) comply with Article 5 of Regulation (EC) No 852/2004, in particular they come from establishments implementing a programme based on the hazard analysis and critical control points (HACCP) principles, and regularly audited by the competent authorities; (b) comply with Article 6(1), point (b), of Regulation (EC) No 853/2004 on the origin of the products of animal origin used in their production; (c) were produced in accordance with the requirements referred to under point II.1; (d) contain processed products of animal origin that were produced in the establishments located in the Member States or in the third countries authorised for the entry into the Union of those processed products of animal origin; ^{(1) (17)} [(e) fulfil the guarantees covering the concerned animals and products thereof, provided by the control plan submitted in accordance with Article 6(2) of Delegated Regulation (EU) 2022/2292, and the third country(ies) or region(s) thereof of the concerned animals’ and products’ origin is/are listed in Annex -I to Implementing Regulation (EU) 2021/405 for the concerned category(ies) of animals and products.] II.3. The composite products ⁽²⁾ described in Part I contain: ⁽¹⁾ either [II.3.A. Meat products ⁽³⁾ in any quantity except gelatine derived from ruminant bones, collagen derived from ruminant bones and highly refined products referred to in Section XVI of Annex III to Regulation (EC) No 853/2004, which: II.3.A.1. meet the animal health requirements laid down in Commission Delegated Regulation (EU) 2020/692 and contain the following meat constituents which are eligible for the entry into the Union as such and meet the following criteria: Species ⁽⁴⁾ Treatment ⁽⁵⁾ Origin ⁽⁶⁾ Approved establishment(s) ⁽⁷⁾ … … … … ; ⁽¹⁾ [II.3.A.2. originate from: ⁽¹⁾ either [the same country as the country of origin in box I.7;] ⁽¹⁾ and/or [Member States;] ^{(8) (1)} and/or [the zone(s) with code(s) … authorised for the entry into the Union of meat products not required to undergo a specific risk-mitigating treatment as set out in Annex XV to Commission Implementing Regulation (EU) 2021/404 with assigned treatment A, and the zone where the composite products were produced is also authorised for the entry into the Union of meat products with assigned treatment A;]] ⁽¹⁾ [II.3.A.3. contain material from bovine, ovine or caprine animals, and with regard to bovine spongiform encephalopathy (BSE), and: ⁽¹⁾ either [the country or region of their origin is classified in accordance with Commission Decision 2007/453/EC as a country or region posing a negligible BSE risk, and: ⁽¹⁾ either [the animals from which the meat products are derived were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;]]] ⁽¹⁾ and/or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals;]]] ⁽¹⁾ and/or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the meat products do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001 of the European Parliament and of the Council; (b) the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity;]]] ⁽¹⁾ and/or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (a) the meat products do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (b) the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (d) the animals from which the meat products are derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (e) the meat products were produced and handled in a manner which ensures that they do not contain and were not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ and/or [the country or region of their origin is classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; ⁽¹⁾ either [(b) the meat products do not contain and are not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals;] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and: ⁽¹⁾ either [(i) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants has been enforced;]] ⁽¹⁾ and/or [(ii) the treated intestines of bovine, ovine and caprine animal origin do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001;]] ⁽¹⁾ either [(c) the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible or a controlled BSE risk;]]] ⁽¹⁾ and/or [(c) the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (i) the animals from which the meat products are derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (ii) the meat products were produced and handled in a manner which ensures that they do not contain and were not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ and/or [the country or region of their origin is classified in accordance with Decision 2007/453/EC as a country or region with an undetermined BSE risk, and: (a) the animals from which the meat products are derived have not been: (i) slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (ii) fed meat-and-bone meal or greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; ⁽¹⁾ either [(b) the meat products do not contain and are not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;]]] ⁽¹⁾ and/or [(b) the meat products contain and are derived from treated intestines sourced from animals which originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and: ⁽¹⁾ either [(i) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants has been enforced;]]]] ⁽¹⁾ and/or [(ii) the treated intestines of bovine, ovine and caprine animal origin do not contain and are not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001.]]]] ⁽¹⁾ and/or [II.3.B. Dairy products or colostrum-based products ⁽⁹⁾ in any quantity that meet the animal health requirements laid down in Delegated Regulation (EU) 2020/692 and therefore are eligible for the entry into the Union as such, and: (a) have been produced in: ^{(1) (10)} either [the zone(s) with code(s) … as listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 which has/have been free from foot and mouth disease and infection with rinderpest virus for the period of at least the last 12 months prior to the date of milking and, during that period, no vaccination against those diseases has been carried out;] ⁽¹⁾ and/or [the zone(s) with code(s) … as listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404 and the treatment applied complies with the minimum treatment provided for in Article 157 of and Annex XXVII to Delegated Regulation (EU) 2020/692;] ^{(1) (10)} and/or [Member States;] and the establishment(s) … (approval number(s) of the establishment(s) of origin of the dairy products or the colostrum-based products contained in the composite products authorised at the date of production for entry into the Union of dairy products or colostrum-based products); (b) originate in: ⁽¹⁾ either [the same country as the country referred to in box I.7;] ^{(1) (10)} and/or [Member States;] ^{(1) (10)} and/or [the zone(s) with code(s) … authorised for the entry into the Union of milk, colostrum, dairy products and colostrum-based products in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404, and the zone where the composite products were produced is also authorised, under the same conditions, for the entry into the Union of milk, colostrum, dairy products and colostrum-based products and listed in Part 1 of that Annex;]] ⁽¹⁾ [(c) are dairy products produced from raw milk and/or dairy products therefrom, and were made from raw milk obtained from ⁽¹⁾ either [[Bos taurus] ⁽¹⁾, [Ovis aries] ⁽¹⁾, [Capra hircus] ⁽¹⁾, [Bubalus bubalis] ⁽¹⁾, [Camelus dromedarius] ⁽¹⁾ and prior to dispatch to the Union have undergone or been produced from raw milk and/or dairy products therefrom, which has/have undergone ^{(1) (10)} either [at least a pasteurisation treatment involving a single heat treatment with a heating effect at least equivalent to that achieved by a pasteurisation process of at least 72°C for 15 seconds and where applicable, sufficient to ensure a negative reaction to an alkaline phosphatase test applied immediately after the heat treatment;]]]] ^{(1) (11)} or [⁽¹⁾ either [a sterilisation process, to achieve an F0 value equal to or greater than 3;]]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time;]]]]] ⁽¹⁾ or [a high temperature short time (HTST) pasteurisation treatment at 72°C for 15 seconds applied twice to milk with a pH equal to or greater than 7,0 achieving, where applicable, a negative reaction to an alkaline phosphatase test, applied immediately after the heat treatment;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment of milk with a pH below 7,0;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment combined with another physical treatment by ⁽¹⁾ either [lowering the pH below 6 for 1 hour;]]]]]] ⁽¹⁾ or [additional heating equal to or greater than 72°C, combined with desiccation;]]]]]] ⁽¹⁾ or [animals other than Bos taurus, Ovis aries, Capra hircus, Bubalus bubalis and Camelus dromedarius, and prior to dispatch to the Union the dairy products have undergone or been produced from raw milk and/or dairy products therefrom which has/have undergone ⁽¹⁾ either [a sterilisation process, to achieve an F0 value equal to or greater than 3;]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time;]]]]] ⁽¹⁾ [(d) are colostrum-based products and come from a zone listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 for entry into the Union of milk, colostrum and colostrum-based products.]] ⁽¹⁾ and/or [II.3.C. Fishery products that originate from approved establishment(s) No(s) … … ⁽¹²⁾ situated in the country(ies) … … ⁽¹³⁾.] ⁽¹⁾ and/or [II.3.D. Egg products that: II.3.D.1. originate from approved establishment(s) No(s) … ⁽¹²⁾ situated in: ⁽¹⁾ either [the zone(s) with code(s) … ⁽¹⁴⁾ which at the date of issue of this animal health/official certificate is/are listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404 for entry into the Union of egg products and applies a disease surveillance programme for highly pathogenic avian influenza that complies with the requirements referred to in Article 160 of Delegated Regulation (EU) 2020/692;] ⁽¹⁾ and/or [Member States;] II.3.D.2. were produced from eggs coming from establishments which satisfy the requirements of Section X of Annex III to Regulation (EC) No 853/2004 in which, during the period of at least the last 30 days prior to the date of collection of the eggs, no outbreak of highly pathogenic avian influenza and infection with Newcastle disease virus has occurred, and: ⁽¹⁾ either [(a) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza during the period of at least the last 30 days prior to the date of collection of the eggs;] ⁽¹⁾ or [(a) the egg products are ⁽¹⁾ either [liquid egg white which was treated ⁽¹⁾ either [with 55,6°C for 870 seconds;]]] ⁽¹⁾ or [with 56,7°C for 232 seconds;]]] ⁽¹⁾ or [10 % salted yolk which was treated with 62,2°C for 138 seconds;]] ⁽¹⁾ or [dried egg white which was treated ⁽¹⁾ either [with 67°C for 20 hours;]]] ⁽¹⁾ or [with 54,4°C for 50,4 hours;]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ or [whole egg blends which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [treated with 61,1°C for 94 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ either [(b) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of infection with Newcastle disease virus during the period of at least the last 30 days prior to the date of collection of the eggs.]] ⁽¹⁾ or [(b) the egg products are ⁽¹⁾ either [liquid egg white which was treated ⁽¹⁾ either [with 55^oC for 2 278 seconds.]]]] ⁽¹⁾ or [with 57^oC for 986 seconds.]]]] ⁽¹⁾ or [with 59^oC for 301 seconds.]]]] ⁽¹⁾ or [10 % salted yolk which was treated with 55^oC for 176 seconds.]]] ⁽¹⁾ or [dried egg white which was treated with 57^oC for 50,4 hours.]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 55^oC for 2 521 seconds.]]]] ⁽¹⁾ or [treated with 57^oC for 1 596 seconds.]]]] ⁽¹⁾ or [treated with 59^oC for 674 seconds.]]]] ⁽¹⁾ or [completely cooked.]]]] ⁽¹⁾ and/or [II.3.E. Gelatine or collagen derived from ruminant bones: II.3.E.1. which originates from approved establishment(s) No(s) … … ⁽¹²⁾ situated in the country(ies) … … ⁽¹⁵⁾; II.3.E.2. for which, with regard to bovine spongiform encephalopathy (BSE), ⁽¹⁾ either [the country or region of its origin is classified in accordance with Decision 2007/453/EC as a country or region posing a negligible bovine spongiform encephalopathy (BSE) risk, and: ⁽¹⁾ either [the animals from which the gelatine or collagen is derived, were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;]]] ⁽¹⁾ and/or [the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and the gelatine or collagen does not contain and is not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals;]]] ⁽¹⁾ and/or [the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the gelatine or collagen does not contain and is not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001 of the European Parliament and of the Council; (b) the gelatine or collagen does not contain and is not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the gelatine or collagen is derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity;]]] ⁽¹⁾ and/or [the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (a) the gelatine or collagen does not contain and is not derived from specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (b) the gelatine or collagen does not contain and is not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (c) the animals from which the gelatine or collagen is derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (d) the animals from which the gelatine or collagen is derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (e) the gelatine or collagen was produced and handled in a manner which ensures that it does not contain and was not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ or [the country or region of its origin is classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and: (a) the animals from which the gelatine or collagen is derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (b) the gelatine or collagen does not contain and is not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; ⁽¹⁾ either [(c) the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible or a controlled BSE risk;]]] ⁽¹⁾ and/or [(c) the animals from which the gelatine or collagen is derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk, and: (i) the animals from which the gelatine or collagen is derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (ii) the gelatine or collagen was produced and handled in a manner which ensures that it does not contain and was not contaminated with nervous and lymphatic tissues exposed during the deboning process;]]] ⁽¹⁾ or [the country or region of its origin is classified in accordance with Decision 2007/453/EC as a country or region with an undetermined BSE risk, and: (a) the animals from which the gelatine or collagen is derived have not been: (i) slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (ii) fed meat-and-bone meal or greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (b) the gelatine or collagen does not contain and is not derived from: (i) specified risk material as defined in point 1 of Annex V to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) nervous and lymphatic tissues exposed during the deboning process;]] ⁽¹⁾ and/or [II.3.F. Processed honey and other processed apiculture products intended for human consumption that originate from listed/registered establishment(s) No(s). … … ⁽¹²⁾ situated in the country(ies) … … ⁽¹⁶⁾.] Notes In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health/official certificate include the United Kingdom in respect of Northern Ireland. This animal health/official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.7 : Insert the ISO code of the country of origin of the composite products containing meat products as listed in Annex XV to Implementing Regulation (EU) 2021/404 or in Annex VII to Implementing Regulation (EU) 2021/405, or colostrum-based products as listed in Annex XVII to Implementing Regulation (EU) 2021/404, or dairy products as listed in Annex XVII or XVIII to Implementing Regulation (EU) 2021/404 or in Annex X to Implementing Regulation (EU) 2021/405, or fishery products as listed in Annex IX to Implementing Regulation (EU) 2021/405, or egg products as listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404, or gelatine and collagen derived from bovine, ovine and caprine animals and intended for human consumption as listed in Annex XII to Implementing Regulation (EU) 2021/405, or honey and apiculture products as listed in Annex -I to Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “honey”. Box reference I.11 : Name, address and registration/approval number (if available) of the establishment(s) of shipping of the composite products. Name of the country of dispatch shall be the same as the country of origin in box I.7. Box reference I.15 : Registration number (railway wagons or container and road vehicles), flight number (aircraft) or name (vessel) shall be provided. In the case of transport in containers, their registration number and, where there is a serial number of the seal, it shall be indicated in box I.19. In the case of unloading and reloading, the consignor shall inform the border control post of entry into the Union. Box reference I.19 : For containers or boxes, the container number and the seal number (if applicable) shall be included. Box reference I.27 : “CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 1517 , 1518 , 1601 00 , 1602 , 1603 00 , 1604 , 1605 , 1702 , 1704 , 1806 , 1901 , 1902 , 1904 , 1905 , 2001 , 2004 , 2005 , 2008 , 2101 , 2103 , 2104 , 2105 00 , 2106 , 2202 or 2208 . “Manufacturing plant”: Insert the name and approval number(s) (if available) of the establishment(s) of production of the composite products. “Nature of commodity”: In the case of composite products containing meat products indicate “meat products”. In the case of composite products containing dairy products indicate “dairy products”. In the case of composite products containing colostrum-based products indicate “colostrum-based products”. In the case of composite products containing fishery products specify whether aquaculture or wild origin. In the case of composite products containing egg products indicate “egg products”. In the case of composite products containing gelatine or collagen derived from ruminant bones indicate “gelatine” or “collagen”, or both. In the case of composite products containing processed honey or other apiculture products indicate “processed honey” or “other processed apiculture products”. Part II: ⁽¹⁾ Keep if appropriate. ⁽²⁾ Composite products shall only be permitted to enter into the Union if the products of animal origin contained therein were obtained after the date of authorisation of the third country or territory, or zone thereof, where the products of animal origin were produced, for the entry into the Union of the specific species and category of products of animal origin, or during a period where animal health restriction measures taken by the Union were not in place against the entry into the Union of those products from that third country or territory, or zone thereof, or during a period where the authorisation of that third country or territory, or zone thereof for the entry into the Union of those products was not suspended. ⁽³⁾ “Meat products” as defined in point 7.1 of Annex I to Regulation (EC) No 853/2004. ⁽⁴⁾ Insert the code for the relevant species of the meat products, where BOV = domestic bovine animals (Bos taurus, Bison bison, Bubalus bubalis and their cross-breeds), OVI = domestic sheep (Ovis aries) and goats (Capra hircus), EQU = domestic solipeds (Equus caballus, Equus asinus and their cross-breeds), POR = domestic porcine animals (Sus scrofa), RM = farmed rabbits, POU = domestic poultry, RAT = ratites, RUF = animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), camelid animals and cervid animals kept as farmed game, RUW = wild animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), wild camelid animals and wild cervid animals, SUF = animals kept as farmed game of wild breeds of porcine animals and animals of the family Tayassuidae, SUW = wild animals of wild breeds of porcine animals and animals of the family Tayassuidae, EQW = wild game solipeds, WL = wild leporidae, WM = wild land mammals other than ungulates and leporidae, GBM = game birds. ⁽⁵⁾ Insert A, B, C, D, E or F for the required treatment as specified and defined in Annex XV to Implementing Regulation (EU) 2021/404. ⁽⁶⁾ Insert the code of the zone of origin of the meat products, as listed in Annex XV to Implementing Regulation (EU) 2021/404 or “EU” for the meat products originating from the Member States. ⁽⁷⁾ Insert the EU approval number of the establishments of origin of the meat products contained in the composite products. ⁽⁸⁾ Delete if the meat products are obtained from EQU, EQW, WL, RM or WM as defined in note (4). ⁽⁹⁾ “Dairy products” mean dairy products for human consumption as defined in point 7.2 of Annex I to Regulation (EC) No 853/2004. “Colostrum-based products” mean colostrum-based products for human consumption as defined in Section IX, point 2, of Annex III to Regulation (EC) No 853/2004. ⁽¹⁰⁾ This certification alternative is only allowed for dairy products originating and produced in the zone(s) listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 or in the Member States, or both and which are contained in the composite products dispatched to the Union from the zone(s) referred to in box I.7 and listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404. ⁽¹¹⁾ This certification alternative is only allowed for dairy products produced in the zone(s) listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404, which are contained in the composite products dispatched to the Union from the zone(s) referred to in box I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. Selected heat treatment shall previously have been applied in the zone referred to in box I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. ⁽¹²⁾ Approval numbers (or registration numbers, in the case of processed honey and other processed apiculture products) of respectively the fishery product establishments, the egg product establishments, the gelatine/collagen establishments, or honey or apiculture products establishments listed in accordance with Article 127(3), point (e), of Regulation (EU) 2017/625 or, if the fishery products, egg products gelatine/collagen, or processed honey and other processed apiculture products originate from the Member States, the approval numbers of the fishery product establishments, the egg product establishments, or the gelatine/collagen establishments approved in accordance with Article 4(2) of Regulation (EC) No 853/2004, or the registration numbers of the honey or apiculture products establishments registered in accordance with Article 6 of Regulation (EC) No 852/2004. ⁽¹³⁾ Country of origin authorised for the entry into the Union of certain fishery products as listed in Annex IX to Implementing Regulation (EU) 2021/405. In the case of fishery products derived from bivalve molluscs, the country of origin shall be authorised for the entry into the Union of live, chilled, frozen or processed bivalve molluscs, echinoderms, tunicates and marine gastropods as listed in Annex VIII to Implementing Regulation (EU) 2021/405. If the fishery products originate from the Member States, the Member State of origin shall be indicated. ⁽¹⁴⁾ Code of the zone as listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404. ⁽¹⁵⁾ Country of origin authorised for the entry into the Union of gelatine and collagen, derived from bovine, ovine and caprine animals, and intended for human consumption as listed in Annex XII to Implementing Regulation (EU) 2021/405. If the gelatine or collagen derived from ruminant bones originates from the Member States, the Member State of origin shall be indicated. ⁽¹⁶⁾ Country of origin authorised for the entry into the Union of honey and apiculture products as listed in Annex -I to Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “honey”. ⁽¹⁷⁾ Not required for gelatine, collagen and fishery products from wild catch. ⁽¹⁸⁾ To be signed by: (a) an official veterinarian, (b) a certifying officer or an official veterinarian for composite products containing only egg products or fishery products.


[Official veterinarian] ^{(1) (18)}/[Certifying officer] ^{(1) (18)}	[Official veterinarian] ^{(1) (18)}/[Certifying officer] ^{(1) (18)}	[Official veterinarian] ^{(1) (18)}/[Certifying officer] ^{(1) (18)}	[Official veterinarian] ^{(1) (18)}/[Certifying officer] ^{(1) (18)}
Name (in capital letters)
Date		Qualification and title
Stamp		Signature

CHAPTER 51 MODEL OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF SPROUTS INTENDED FOR HUMAN CONSUMPTION AND SEEDS INTENDED FOR THE PRODUCTION OF SPROUTS FOR HUMAN CONSUMPTION (MODEL SPR)

Part I: Description of consignment


COUNTRY	Official certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for
	☐ Products for human consumption

---	---
I.21	I.22
I.21	I.23

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species




☐ Final consumer

Part II: Certification


	COUNTRY	Model certificate SPR	Model certificate SPR	Model certificate SPR	Model certificate SPR
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


II.1. Public health attestation I, the undersigned, hereby declare that I am aware of the relevant requirements of Regulation (EC) No 178/2002 of the European Parliament and of the Council and Regulation (EC) No 852/2004 of the European Parliament and of the Council, and hereby certify that ⁽¹⁾ either [the seeds intended for the production of sprouts described in Part I were produced under conditions which comply with Regulation (EC) No 852/2004 and in particular with the general hygiene requirements for primary production and associated operations set out in Part A of Annex I thereto.] ⁽¹⁾ or [the sprouts described in Part I were produced: (a) under conditions which comply with Regulation (EC) No 852/2004 and in particular with the general hygiene requirements for primary production and associated operations set out in Part A of Annex I thereto; (b) in establishments approved in accordance with the requirements laid down in Article 2 of Commission Regulation (EU) No 210/2013; (c) under conditions which comply with the traceability requirements laid down in Commission Implementing Regulation (EU) No 208/2013 and respect the criteria laid down in Annex I to Commission Regulation (EC) No 2073/2005.] Notes In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this official certificate include the United Kingdom in respect of Northern Ireland. This official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0704 90 , 0706 90 , 0708 10 , 0708 20 , 0708 90 , 0713 10 , 0713 33 , 0713 34 , 0713 35 , 0713 39 , 0713 40 , 0713 50 , 0713 60 , 0713 90 , 0910 99 , 1201 10 , 1201 90 , 1207 50 , 1207 99 , 1209 10 , 1209 21 1209 91 or 1214 90 . “Manufacturing plant”: Insert the name of the establishments which produced the sprouts or seeds. Part II: ⁽¹⁾ Delete if not applicable.

II.1. Public health attestation I, the undersigned, hereby declare that I am aware of the relevant requirements of Regulation (EC) No 178/2002 of the European Parliament and of the Council and Regulation (EC) No 852/2004 of the European Parliament and of the Council, and hereby certify that ⁽¹⁾ either [the seeds intended for the production of sprouts described in Part I were produced under conditions which comply with Regulation (EC) No 852/2004 and in particular with the general hygiene requirements for primary production and associated operations set out in Part A of Annex I thereto.] ⁽¹⁾ or [the sprouts described in Part I were produced: (a) under conditions which comply with Regulation (EC) No 852/2004 and in particular with the general hygiene requirements for primary production and associated operations set out in Part A of Annex I thereto; (b) in establishments approved in accordance with the requirements laid down in Article 2 of Commission Regulation (EU) No 210/2013; (c) under conditions which comply with the traceability requirements laid down in Commission Implementing Regulation (EU) No 208/2013 and respect the criteria laid down in Annex I to Commission Regulation (EC) No 2073/2005.] Notes In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this official certificate include the United Kingdom in respect of Northern Ireland. This official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0704 90 , 0706 90 , 0708 10 , 0708 20 , 0708 90 , 0713 10 , 0713 33 , 0713 34 , 0713 35 , 0713 39 , 0713 40 , 0713 50 , 0713 60 , 0713 90 , 0910 99 , 1201 10 , 1201 90 , 1207 50 , 1207 99 , 1209 10 , 1209 21 1209 91 or 1214 90 . “Manufacturing plant”: Insert the name of the establishments which produced the sprouts or seeds. Part II: ⁽¹⁾ Delete if not applicable.


Certifying officer	Certifying officer	Certifying officer	Certifying officer
Name (in capital letters)
Date		Qualification and title
Stamp		Signature

CHAPTER 52 MODEL ANIMAL HEALTH CERTIFICATE FOR THE TRANSIT THROUGH THE UNION TO A THIRD COUNTRY EITHER BY IMMEDIATE TRANSIT OR AFTER STORAGE IN THE UNION OF NON-SHELF-STABLE COMPOSITE PRODUCTS INTENDED FOR HUMAN CONSUMPTION AND SHELF-STABLE COMPOSITE PRODUCTS INTENDED FOR HUMAN CONSUMPTION AND CONTAINING ANY QUANTITY OF MEAT PRODUCTS EXCEPT GELATINE, COLLAGEN AND HIGHLY REFINED PRODUCTS, AND ANY QUANTITY OF COLOSTRUM-BASED PRODUCTS (MODEL TRANSIT-COMP)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for
	☐ Products for human consumption


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code



Slaughterhouse

☐ Final consumer

Part II: Certification


COUNTRY	COUNTRY	Certificate model TRANSIT-COMP	Certificate model TRANSIT-COMP	Certificate model TRANSIT-COMP	Certificate model TRANSIT-COMP
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned, hereby certify that the composite products ⁽²⁾ described in Part I contain: ⁽¹⁾ either [II.A. Meat products ⁽³⁾ in any quantity except gelatine, collagen and highly refined products referred to in Section XVI of Annex III to Regulation (EC) No 853/2004 of the European Parliament and of the Council, which: II.A.1. meet the animal health requirements laid down in Commission Delegated Regulation (EU) 2020/692 and contain the following meat constituents which are eligible for the entry into the Union as such and meet the following criteria: Species ⁽⁴⁾ Treatment ⁽⁵⁾ Origin ⁽⁶⁾ … … … ; II.A.2. originate from: ⁽¹⁾ either [the same country as the country referred to in box I.7;]] ⁽¹⁾ and/or [Member States;]] ^{(1) (7)} and/or [the zone(s) with code(s) … which at the date of issue of this animal health certificate is/are authorised for the entry into the Union of meat products not required to undergo a specific risk-mitigating treatment as set out in Annex XV to Commission Implementing Regulation (EU) 2021/404 with assigned treatment A, and the zone where the composite products were produced is also authorised for the entry into the Union of meat products with assigned treatment A.]] ⁽¹⁾ and/or [II.B. Dairy products or colostrum-based products ⁽⁸⁾ in any quantity that meet the animal health requirements laid down in Delegated Regulation (EU) 2020/692 and therefore are eligible for the entry into the Union as such, and: (a) have been produced in: ^{(9) (1)} either [the zone(s) with code(s) … as listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 which has/have been free from foot and mouth disease and infection with rinderpest virus for the period of at least the last 12 months prior to the date of milking and, during that period, no vaccination against those diseases has been carried out;] ⁽¹⁾ and/or [the zone(s) with code(s) … as listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404 and the treatment applied complies with the minimum treatment provided for in Article 157 of and Annex XXVII to Delegated Regulation (EU) 2020/692;] ^{(1) (9)} and/or [Member States;] (b) originate in: ⁽¹⁾ either [the same country as the country referred to in box I.7;] ^{(1) (9)} and/or [Member States;] ^{(1) (9)} and/or [the zone(s) with code(s) … authorised for the entry into the Union of milk, colostrum, dairy products and colostrum-based products and listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404, and the zone where the composite products were produced is also authorised, under the same conditions, for the entry into the Union of milk, colostrum, dairy products and colostrum-based products and listed in that Annex;] ⁽¹⁾ [(c) are dairy products produced from raw milk and/or dairy products therefrom, and were made from raw milk obtained from ⁽¹⁾ either [[Bos taurus] ⁽¹⁾, [Ovis aries] ⁽¹⁾, [Capra hircus] ⁽¹⁾, [Bubalus bubalis] ⁽¹⁾, [Camelus dromedarius] ⁽¹⁾, and prior to dispatch to the Union the dairy products have undergone or been produced from raw milk and/or dairy products therefrom, which has/have undergone ^{(1) (9)} either [at least a pasteurisation treatment involving a single heat treatment with a heating effect at least equivalent to that achieved by a pasteurisation process of at least 72°C for 15 seconds and where applicable, sufficient to ensure a negative reaction to an alkaline phosphatase test applied immediately after the heat treatment;]]]] ^{(1) (10)} or [⁽¹⁾ either [a sterilisation process, to achieve an Fo value equal to or greater than 3;]]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time;]]]]] ⁽¹⁾ or [a high temperature short time (HTST) pasteurisation treatment at 72°C for 15 seconds, applied twice to milk with a pH equal to or greater than 7,0 achieving, where applicable, a negative reaction to an alkaline phosphatase test, applied immediately after the heat treatment;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment of milk with a pH below 7,0;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment combined with another physical treatment by ⁽¹⁾ either [lowering the pH below 6 for 1 hour.]]]]]] ⁽¹⁾ or [additional heating equal to or greater than 72°C, combined with desiccation.]]]]]] ⁽¹⁾ or [animals other than Bos taurus, Ovis aries, Capra hircus, Bubalus bubalis and Camelus dromedarius and prior to dispatch to the Union have undergone or been produced from raw milk and/or dairy products therefrom, which has/have undergone ⁽¹⁾ either [a sterilisation process, to achieve an Fo value equal to or greater than 3.]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time.]]]] ⁽¹⁾ [(d) are colostrum-based products and they come from a third country or territory listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 for entry of milk, colostrum and colostrum-based products.]] ⁽¹⁾ and/or [II.C. Egg products that: II.C.1. originate from: ⁽¹⁾ either [the zone(s) with code(s) … ⁽¹¹⁾ which at the date of issue of this animal health certificate is/are listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404 for entry into the Union of egg products and applies a disease surveillance programme for highly pathogenic avian influenza that complies with the requirements referred to in Article 160 of Delegated Regulation (EU) 2020/692;]] ⁽¹⁾ and/or [Member States;]] II.C.2. were produced from eggs coming from establishments which satisfies the requirements of Section X of Annex III to Regulation (EC) No 853/2004 in which, during the period of at least the last 30 days prior to the date of collection of the eggs, no outbreak of highly pathogenic avian influenza and infection with Newcastle disease virus has occurred, and: ⁽¹⁾ either [(a) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza during the period of at least the last 30 days prior to the date of collection of the eggs;] ⁽¹⁾ or [(a) the egg products are ⁽¹⁾ either [liquid egg which white was treated ⁽¹⁾ either [with 55,6°C for 870 seconds;]]] ⁽¹⁾ or [with 56,7°C for 232 seconds;]]] ⁽¹⁾ or [10 % salted yolk which was treated with 62,2°C for 138 seconds;]] ⁽¹⁾ or [dried egg white which was treated ⁽¹⁾ either [with 67°C for 20 hours;]]] ⁽¹⁾ or [with 54,4°C for 50,4 hours;]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ or [whole egg blends which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [treated with 61,1°C for 94 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ either [(b) within a 10 km radius of which, including where appropriate, the territory of a neighbouring country there has been no outbreak of infection with Newcastle disease virus during the period of at least the last 30 days prior to the date of collection of the eggs.]] ⁽¹⁾ or [(b) the egg products are ⁽¹⁾ either [liquid egg white which was treated ⁽¹⁾ either [with 55^oC for 2 278 seconds.]]]] ⁽¹⁾ or [with 57^oC for 986 seconds.]]]] ⁽¹⁾ or [with 59^oC for 301 seconds.]]]] ⁽¹⁾ or [10 % salted yolk which was treated with 55^oC for 176 seconds.]]] ⁽¹⁾ or [dried egg white which was treated with 57^oC for 50,4 hours.]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 55^oC for 2 521 seconds.]]]] ⁽¹⁾ or [treated with 57^oC for 1 596 seconds.]]]] ⁽¹⁾ or [treated with 59^oC for 674 seconds.]]]] ⁽¹⁾ or [completely cooked.]]]] Notes In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate is intended for the entry into the Union of composite products containing meat products, dairy products, colostrum-based products or egg products for which the Union is not the final destination. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.7 : Insert the ISO code of the country of origin of the composite products containing meat products as listed in Annex XV to Implementing Regulation (EU) 2021/404 or in Annex VII to Implementing Regulation (EU) 2021/405, or for colostrum-based products as listed in Annex XVII to Implementing Regulation (EU) 2021/404, or for dairy products as listed in Annex XVII or XVIII to Implementing Regulation (EU) 2021/404 or in Annex X to Implementing Regulation (EU) 2021/405, or for processed egg products as listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404. Box reference I.11 : Name, address and registration/approval number (if available) of the establishments of shipping of the composite products. Name of the country of dispatch which shall be the same as the country of origin in box I.7. Box reference I.15 : Registration number (railway wagons or container and road vehicles), flight number (aircraft) or name (vessel) shall be provided. In the case of transport in containers, their registration number and, where there is a serial number of the seal, it shall be indicated in box I.19. In the case of unloading and reloading, the consignor shall inform the border control post of entry into the Union. Box reference I.19 : For containers or boxes, the container number and the seal number (if applicable) shall be included. Box reference I.27 : “CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 1517 , 1518 , 1601 00 , 1602 , 1603 00 , 1604 , 1605 , 1702 , 1704 , 1806 , 1901 , 1902 , 1904 , 1905 , 2001 , 2004 , 2005 , 2101 , 2103 , 2104 , 2105 00 , 2106 , 2202 or 2208 . “Nature of commodity”: In the case of composite products containing meat products, indicate “meat products”. In the case of composite products containing dairy products, indicate “dairy products”. In the case of composite products containing colostrum-based products, indicate “colostrum-based products”. In the case of composite products containing egg products, indicate “egg products”. Part II: ⁽¹⁾ Keep if appropriate. ⁽²⁾ Composite products shall only be permitted to enter into the Union if the products of animal origin contained therein were obtained after the date of authorisation of the third country or territory, or zone thereof, where the products of animal origin were produced, for the entry into the Union of the specific species and category of products of animal origin, or during a period where animal health restriction measures taken by the Union were not in place against the entry into the Union of those products from that third country or territory, or zone thereof, or during a period where the authorisation of that third country or territory, or zone thereof for the entry into the Union of those products was not suspended. ⁽³⁾ “Meat products” as defined in point 7.1 of Annex I to Regulation (EC) No 853/2004. ⁽⁴⁾ Insert the code for the relevant species of meat products, where BOV = domestic bovine animals (Bos taurus, Bison bison, Bubalus bubalis and their cross-breeds), OVI = domestic sheep (Ovis aries) and goats (Capra hircus), POR = domestic porcine animals (Sus scrofa), POU = domestic poultry, RAT = ratites, RUF = animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), camelid animals and cervid animals kept as farmed game, RUW = wild animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), wild camelid animals and wild cervid animals, SUF = animals kept as farmed game of wild breeds of porcine animals and animals of the family Tayassuidae, SUW = wild animals of wild breeds of porcine animals and animals of the family Tayassuidae. ⁽⁵⁾ Insert A, B, C, D, E or F for the required treatment as specified and defined in Annex XV to Implementing Regulation (EU) 2021/404. ⁽⁶⁾ Insert the code of the zone of origin of the meat products as listed in Annex XV to Implementing Regulation (EU) 2021/404 or “EU” for the meat products originating from the Member States. ⁽⁷⁾ Delete if the meat products are obtained from EQU = domestic solipeds (Equus caballus, Equus asinus and their cross-breeds), EQW = wild game solipeds, WL = wild leporidae, RM = farmed rabbits or WM = wild land mammals other than ungulates and leporidae. ⁽⁸⁾ “Dairy products” mean dairy products for human consumption as defined in point 7.2 of Annex I to Regulation (EC) No 853/2004. “Colostrum-based products” mean colostrum-based products for human consumption as defined in Section IX, point 2, of Annex III to Regulation (EC) No 853/2004. ⁽⁹⁾ This certification alternative is only allowed for dairy products originating and produced in the zone(s) listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404, or in the Member States, or both and which are contained in the composite products dispatched to the Union from the zone(s) referred to in box. I.7 and listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404. ⁽¹⁰⁾ This certification alternative is only allowed for dairy products produced in the zone(s) listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404, which are contained in the composite products dispatched to the Union from the zone(s) referred to in box. I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. Selected heat treatment shall previously have been applied in the zone referred to in box. I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. ⁽¹¹⁾ Code of the zone in accordance with column 2 of the table in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404.

I, the undersigned, hereby certify that the composite products ⁽²⁾ described in Part I contain: ⁽¹⁾ either [II.A. Meat products ⁽³⁾ in any quantity except gelatine, collagen and highly refined products referred to in Section XVI of Annex III to Regulation (EC) No 853/2004 of the European Parliament and of the Council, which: II.A.1. meet the animal health requirements laid down in Commission Delegated Regulation (EU) 2020/692 and contain the following meat constituents which are eligible for the entry into the Union as such and meet the following criteria: Species ⁽⁴⁾ Treatment ⁽⁵⁾ Origin ⁽⁶⁾ … … … ; II.A.2. originate from: ⁽¹⁾ either [the same country as the country referred to in box I.7;]] ⁽¹⁾ and/or [Member States;]] ^{(1) (7)} and/or [the zone(s) with code(s) … which at the date of issue of this animal health certificate is/are authorised for the entry into the Union of meat products not required to undergo a specific risk-mitigating treatment as set out in Annex XV to Commission Implementing Regulation (EU) 2021/404 with assigned treatment A, and the zone where the composite products were produced is also authorised for the entry into the Union of meat products with assigned treatment A.]] ⁽¹⁾ and/or [II.B. Dairy products or colostrum-based products ⁽⁸⁾ in any quantity that meet the animal health requirements laid down in Delegated Regulation (EU) 2020/692 and therefore are eligible for the entry into the Union as such, and: (a) have been produced in: ^{(9) (1)} either [the zone(s) with code(s) … as listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 which has/have been free from foot and mouth disease and infection with rinderpest virus for the period of at least the last 12 months prior to the date of milking and, during that period, no vaccination against those diseases has been carried out;] ⁽¹⁾ and/or [the zone(s) with code(s) … as listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404 and the treatment applied complies with the minimum treatment provided for in Article 157 of and Annex XXVII to Delegated Regulation (EU) 2020/692;] ^{(1) (9)} and/or [Member States;] (b) originate in: ⁽¹⁾ either [the same country as the country referred to in box I.7;] ^{(1) (9)} and/or [Member States;] ^{(1) (9)} and/or [the zone(s) with code(s) … authorised for the entry into the Union of milk, colostrum, dairy products and colostrum-based products and listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404, and the zone where the composite products were produced is also authorised, under the same conditions, for the entry into the Union of milk, colostrum, dairy products and colostrum-based products and listed in that Annex;] ⁽¹⁾ [(c) are dairy products produced from raw milk and/or dairy products therefrom, and were made from raw milk obtained from ⁽¹⁾ either [[Bos taurus] ⁽¹⁾, [Ovis aries] ⁽¹⁾, [Capra hircus] ⁽¹⁾, [Bubalus bubalis] ⁽¹⁾, [Camelus dromedarius] ⁽¹⁾, and prior to dispatch to the Union the dairy products have undergone or been produced from raw milk and/or dairy products therefrom, which has/have undergone ^{(1) (9)} either [at least a pasteurisation treatment involving a single heat treatment with a heating effect at least equivalent to that achieved by a pasteurisation process of at least 72°C for 15 seconds and where applicable, sufficient to ensure a negative reaction to an alkaline phosphatase test applied immediately after the heat treatment;]]]] ^{(1) (10)} or [⁽¹⁾ either [a sterilisation process, to achieve an Fo value equal to or greater than 3;]]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time;]]]]] ⁽¹⁾ or [a high temperature short time (HTST) pasteurisation treatment at 72°C for 15 seconds, applied twice to milk with a pH equal to or greater than 7,0 achieving, where applicable, a negative reaction to an alkaline phosphatase test, applied immediately after the heat treatment;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment of milk with a pH below 7,0;]]]]] ⁽¹⁾ or [HTST pasteurisation treatment combined with another physical treatment by ⁽¹⁾ either [lowering the pH below 6 for 1 hour.]]]]]] ⁽¹⁾ or [additional heating equal to or greater than 72°C, combined with desiccation.]]]]]] ⁽¹⁾ or [animals other than Bos taurus, Ovis aries, Capra hircus, Bubalus bubalis and Camelus dromedarius and prior to dispatch to the Union have undergone or been produced from raw milk and/or dairy products therefrom, which has/have undergone ⁽¹⁾ either [a sterilisation process, to achieve an Fo value equal to or greater than 3.]]]] ⁽¹⁾ or [an ultra-high temperature (UHT) treatment at not less than 135°C in combination with a suitable holding time.]]]] ⁽¹⁾ [(d) are colostrum-based products and they come from a third country or territory listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404 for entry of milk, colostrum and colostrum-based products.]] ⁽¹⁾ and/or [II.C. Egg products that: II.C.1. originate from: ⁽¹⁾ either [the zone(s) with code(s) … ⁽¹¹⁾ which at the date of issue of this animal health certificate is/are listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404 for entry into the Union of egg products and applies a disease surveillance programme for highly pathogenic avian influenza that complies with the requirements referred to in Article 160 of Delegated Regulation (EU) 2020/692;]] ⁽¹⁾ and/or [Member States;]] II.C.2. were produced from eggs coming from establishments which satisfies the requirements of Section X of Annex III to Regulation (EC) No 853/2004 in which, during the period of at least the last 30 days prior to the date of collection of the eggs, no outbreak of highly pathogenic avian influenza and infection with Newcastle disease virus has occurred, and: ⁽¹⁾ either [(a) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza during the period of at least the last 30 days prior to the date of collection of the eggs;] ⁽¹⁾ or [(a) the egg products are ⁽¹⁾ either [liquid egg which white was treated ⁽¹⁾ either [with 55,6°C for 870 seconds;]]] ⁽¹⁾ or [with 56,7°C for 232 seconds;]]] ⁽¹⁾ or [10 % salted yolk which was treated with 62,2°C for 138 seconds;]] ⁽¹⁾ or [dried egg white which was treated ⁽¹⁾ either [with 67°C for 20 hours;]]] ⁽¹⁾ or [with 54,4°C for 50,4 hours;]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ or [whole egg blends which were ⁽¹⁾ either [treated with 60°C for 188 seconds;]]] ⁽¹⁾ or [treated with 61,1°C for 94 seconds;]]] ⁽¹⁾ or [completely cooked;]]] ⁽¹⁾ either [(b) within a 10 km radius of which, including where appropriate, the territory of a neighbouring country there has been no outbreak of infection with Newcastle disease virus during the period of at least the last 30 days prior to the date of collection of the eggs.]] ⁽¹⁾ or [(b) the egg products are ⁽¹⁾ either [liquid egg white which was treated ⁽¹⁾ either [with 55^oC for 2 278 seconds.]]]] ⁽¹⁾ or [with 57^oC for 986 seconds.]]]] ⁽¹⁾ or [with 59^oC for 301 seconds.]]]] ⁽¹⁾ or [10 % salted yolk which was treated with 55^oC for 176 seconds.]]] ⁽¹⁾ or [dried egg white which was treated with 57^oC for 50,4 hours.]]] ⁽¹⁾ or [whole eggs which were ⁽¹⁾ either [treated with 55^oC for 2 521 seconds.]]]] ⁽¹⁾ or [treated with 57^oC for 1 596 seconds.]]]] ⁽¹⁾ or [treated with 59^oC for 674 seconds.]]]] ⁽¹⁾ or [completely cooked.]]]] Notes In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate is intended for the entry into the Union of composite products containing meat products, dairy products, colostrum-based products or egg products for which the Union is not the final destination. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.7 : Insert the ISO code of the country of origin of the composite products containing meat products as listed in Annex XV to Implementing Regulation (EU) 2021/404 or in Annex VII to Implementing Regulation (EU) 2021/405, or for colostrum-based products as listed in Annex XVII to Implementing Regulation (EU) 2021/404, or for dairy products as listed in Annex XVII or XVIII to Implementing Regulation (EU) 2021/404 or in Annex X to Implementing Regulation (EU) 2021/405, or for processed egg products as listed in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404. Box reference I.11 : Name, address and registration/approval number (if available) of the establishments of shipping of the composite products. Name of the country of dispatch which shall be the same as the country of origin in box I.7. Box reference I.15 : Registration number (railway wagons or container and road vehicles), flight number (aircraft) or name (vessel) shall be provided. In the case of transport in containers, their registration number and, where there is a serial number of the seal, it shall be indicated in box I.19. In the case of unloading and reloading, the consignor shall inform the border control post of entry into the Union. Box reference I.19 : For containers or boxes, the container number and the seal number (if applicable) shall be included. Box reference I.27 : “CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 1517 , 1518 , 1601 00 , 1602 , 1603 00 , 1604 , 1605 , 1702 , 1704 , 1806 , 1901 , 1902 , 1904 , 1905 , 2001 , 2004 , 2005 , 2101 , 2103 , 2104 , 2105 00 , 2106 , 2202 or 2208 . “Nature of commodity”: In the case of composite products containing meat products, indicate “meat products”. In the case of composite products containing dairy products, indicate “dairy products”. In the case of composite products containing colostrum-based products, indicate “colostrum-based products”. In the case of composite products containing egg products, indicate “egg products”. Part II: ⁽¹⁾ Keep if appropriate. ⁽²⁾ Composite products shall only be permitted to enter into the Union if the products of animal origin contained therein were obtained after the date of authorisation of the third country or territory, or zone thereof, where the products of animal origin were produced, for the entry into the Union of the specific species and category of products of animal origin, or during a period where animal health restriction measures taken by the Union were not in place against the entry into the Union of those products from that third country or territory, or zone thereof, or during a period where the authorisation of that third country or territory, or zone thereof for the entry into the Union of those products was not suspended. ⁽³⁾ “Meat products” as defined in point 7.1 of Annex I to Regulation (EC) No 853/2004. ⁽⁴⁾ Insert the code for the relevant species of meat products, where BOV = domestic bovine animals (Bos taurus, Bison bison, Bubalus bubalis and their cross-breeds), OVI = domestic sheep (Ovis aries) and goats (Capra hircus), POR = domestic porcine animals (Sus scrofa), POU = domestic poultry, RAT = ratites, RUF = animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), camelid animals and cervid animals kept as farmed game, RUW = wild animals of the family Bovidae (other than domestic bovine, ovine and caprine animals), wild camelid animals and wild cervid animals, SUF = animals kept as farmed game of wild breeds of porcine animals and animals of the family Tayassuidae, SUW = wild animals of wild breeds of porcine animals and animals of the family Tayassuidae. ⁽⁵⁾ Insert A, B, C, D, E or F for the required treatment as specified and defined in Annex XV to Implementing Regulation (EU) 2021/404. ⁽⁶⁾ Insert the code of the zone of origin of the meat products as listed in Annex XV to Implementing Regulation (EU) 2021/404 or “EU” for the meat products originating from the Member States. ⁽⁷⁾ Delete if the meat products are obtained from EQU = domestic solipeds (Equus caballus, Equus asinus and their cross-breeds), EQW = wild game solipeds, WL = wild leporidae, RM = farmed rabbits or WM = wild land mammals other than ungulates and leporidae. ⁽⁸⁾ “Dairy products” mean dairy products for human consumption as defined in point 7.2 of Annex I to Regulation (EC) No 853/2004. “Colostrum-based products” mean colostrum-based products for human consumption as defined in Section IX, point 2, of Annex III to Regulation (EC) No 853/2004. ⁽⁹⁾ This certification alternative is only allowed for dairy products originating and produced in the zone(s) listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404, or in the Member States, or both and which are contained in the composite products dispatched to the Union from the zone(s) referred to in box. I.7 and listed in Part 1 of Annex XVII to Implementing Regulation (EU) 2021/404. ⁽¹⁰⁾ This certification alternative is only allowed for dairy products produced in the zone(s) listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404, which are contained in the composite products dispatched to the Union from the zone(s) referred to in box. I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. Selected heat treatment shall previously have been applied in the zone referred to in box. I.7 and listed in Part 1 of Annex XVIII to Implementing Regulation (EU) 2021/404. ⁽¹¹⁾ Code of the zone in accordance with column 2 of the table in Part 1 of Annex XIX to Implementing Regulation (EU) 2021/404.


Official veterinarian	Official veterinarian	Official veterinarian	Official veterinarian
Name (in capital letters)
Date		Qualification and title
Stamp		Signature

CHAPTER 53 MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF PRODUCTS OF ANIMAL ORIGIN AND CERTAIN GOODS THAT ORIGINATE IN THE UNION, ARE MOVED TO A THIRD COUNTRY OR TERRITORY AND MOVED BACK TO THE UNION AFTER UNLOADING, STORAGE AND RELOADING IN THAT THIRD COUNTRY OR TERRITORY (MODEL STORAGE-TC-PAO)

Part I: Description of consignment


COUNTRY	Animal health/official certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for
	☐ Products for human consumption

---	---
I.21


---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species


☐ Final consumer

Part II: Certification


COUNTRY	COUNTRY	Certificate model STORAGE-TC-PAO	Certificate model STORAGE-TC-PAO	Certificate model STORAGE-TC-PAO	Certificate model STORAGE-TC-PAO
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.